Methods of treating inflammatory and autoimmune diseases with natalizumab | Patent Number 11292845
US 11292845 B2Filled DateMar 18, 2019
Priority DateFeb 28, 2006
Publication DateOct 17, 2019
Expiration DateFeb 27, 2026
Inventor/ApplicantsIvan Lieberburg
ExaminesGAMBEL, PHILLIP
Art Unit1644
Technology Center1600
Law Firm
You must be logged in to view
LoginAttorneys
Subscription-Only
View Concierge ProgramEmpower your practice with Patexia Publication Prosecution IP Module.
Get access to our exclusive rankings and unlock powerful data.
Looking for a Publication Attorney?
Get in touch with our team or create your account to start exploring a
network of over 120K attorneys.